Tilray Brands, Inc. (TLRY)

NasdaqGS • Currently down 0.06 (-1.20%) in today's trading session

1 member of Congress has disclosed 20 trades in Tilray Brands, Inc. (TLRY) via STOCK Act filings. The most recent disclosure was a sale by Brian J. Mast on 18 April 2022. Aggregate disclosed activity totals roughly $195K in purchases and $493K in sales (midpoint estimates from bracketed disclosure amounts).

Tilray Brands, Inc. is currently trading at $4.51, positioned at 4% of its 52-week range ($3.67 – $23.20).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$4.51
24h Change
-0.06 (-1.20%)
52 Week Range
$3.67—$23.20
View on NASDAQ

Tilray Brands, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TLRY

Select to highlight on chart
9 transactions
Compliance: 45%
Brian J. Mast18 Apr 20229 May 2022SaleStock$1,001 - $15,000N/A
Brian J. Mast3 May 20215 Oct 2022Stock$1,001 - $15,000N/A
Brian J. Mast10 Feb 202112 Aug 2022SaleStock$50,001 - $100,000N/A
Brian J. Mast10 Feb 202117 Mar 2021SaleStock$50,001 - $100,000N/A
Brian J. Mast9 Feb 202112 Aug 2022SaleStock$15,001 - $50,000N/A
Brian J. Mast9 Feb 202112 Aug 2022SaleStock$15,001 - $50,000N/A
Brian J. Mast9 Feb 202117 Mar 2021SaleStock$15,001 - $50,000N/A
Brian J. Mast9 Feb 202117 Mar 2021SaleStock$15,001 - $50,000N/A
Brian J. Mast6 Nov 20201 Dec 2020PurchaseStock$15,001 - $50,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$504.92M

Volume

1.16M

Beta

1.91

P/E Ratio

-4.16

Fundamentals

EPS

$-1.08

Div. Yield

—

Open

$4.55

Day Range

$4.49 — $4.60

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ · USD
Country
CA
CEO
Irwin David Simon
IPO Date
2018-07-19
Website
www.tilray.com

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, t...

Earnings

Next Report

Q3 2026

8 Oct

EPS Est.

$-0.18

Rev. Est.

$269.4M

Days Until

41

Recent Quarters

Q2 202628 Jul
EPS$-0.43
Miss 3471.4%
Q1 20261 Apr
EPS$-0.24
Miss 71.4%
Q4 20258 Jan
EPS$-0.41
Miss 192.9%
Q3 20259 Oct
EPS$-0.00
Beat 98.5%
Q2 202528 Jul
EPS$0.20
Beat 185.1%
Q1 20258 Apr
EPS$-1.00
Miss 150.0%
Q4 202410 Jan
EPS$-1.00
Miss 2400.0%
Q3 202410 Oct
EPS$-0.40
Miss 1042.9%
Q2 202429 Jul
EPS$-0.40
Miss 100.0%
Q1 20249 Apr
EPS$-0.12
Miss 140.0%
Q4 20239 Jan
EPS$-0.70
Miss 1066.7%
Q3 20234 Oct
EPS$-1.00
Miss 1851.2%
Q2 202326 Jul
EPS$-0.15
Miss 200.0%
Q1 202310 Apr
EPS$-1.90
Miss 3310.5%
Q4 20229 Jan
EPS$-0.11
Miss 94.1%
Q3 20227 Oct
EPS$-0.80
Miss 1042.9%
Q2 202228 Jul
EPS$-3.40
Miss 4150.0%
Q1 20226 Apr
EPS$0.09
Beat 210.0%
Q4 202110 Jan
EPS$0.03
Beat 133.3%
Q3 20217 Oct
EPS$-0.80
Miss 33.3%
Q2 202128 Jul
EPS$-0.11
Beat 86.3%
Q1 202110 May
EPS$-1.75
Miss 2087.5%
Q4 202017 Feb
EPS$-0.80
Beat 42.9%
Q3 20209 Nov
EPS$-1.42
Beat 32.4%
Q2 202010 Aug
EPS$-2.60
Beat 3.7%
Q1 202011 May
EPS$-1.73
Miss 284.4%
Q3 201912 Nov
EPS$-0.36
Miss 24.1%
Q2 201913 Aug
EPS$-3.20
Miss 39.1%
Q1 201914 May
EPS$-2.70
Miss 8.0%
Q3 201813 Nov
EPS$-0.20
Beat 85.7%
Q2 201828 Aug
EPS$-0.17
Miss 112.5%
Q4 201728 Feb
EPS$0.06
Q3 201730 Nov
EPS$0.03
Q2 201731 Aug
EPS$0.08
Q1 201731 May
EPS$-0.01
Q4 201628 Feb
EPS$0.03
Q3 201630 Nov
EPS$0.01
Q2 201631 Aug
EPS$0.01
Q1 201631 May
EPS$0.01
Q4 201529 Feb
EPS$0.00
Q3 201530 Nov
EPS$-0.01
Q2 201531 Aug
EPS$-0.01
Q1 201531 May
EPS$-0.01
Q4 201428 Feb
EPS$-0.05
Q3 201430 Nov
EPS$-0.00
Q2 201431 Aug
EPS$-0.00
Q1 201431 May
EPS$-0.02
Q4 201328 Feb
EPS$-0.01
Q3 201330 Nov
EPS$-0.00
Q2 201331 Aug
EPS$-0.00
Q1 201331 May
EPS$-0.00
Q4 201228 Feb
EPS$-0.00
Q3 201230 Nov
EPS$-0.01
Q2 201231 Aug
EPS$-0.00
Q1 201231 May
EPS$-0.00
Q4 201129 Feb
EPS$-0.03
Q3 201130 Nov
EPS$-0.01

4 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about TLRY

Which members of Congress have traded TLRY?
1 member of Congress has disclosed 20 trade in Tilray Brands, Inc. (TLRY) under the STOCK Act: Brian J. Mast.
When was TLRY most recently disclosed by Congress?
The most recent TLRY disclosure was a sale by Brian J. Mast on 18 April 2022.
What is the total disclosed congressional trading volume for TLRY?
Members of Congress have disclosed approximately $195K in TLRY purchases and $493K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in TLRY?
This TLRY page updates as soon as new STOCK Act disclosures are filed for Tilray Brands, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.